Medacta
Medacta International SA, headquartered in Switzerland (CH), is a leading player in the global medical device industry, specialising in orthopaedic and spinal surgery solutions. Founded in 1999, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Medacta is renowned for its innovative products, such as the M.O.R.E. (Medacta Orthopaedic Research and Education) programme, which enhances surgical techniques and patient outcomes. The company’s commitment to advanced technology and minimally invasive procedures sets it apart in the competitive landscape. With a focus on quality and precision, Medacta has achieved significant milestones, including numerous regulatory approvals and a growing portfolio of patented technologies. Its dedication to improving surgical performance and patient care solidifies its position as a trusted name in orthopaedics and spinal surgery.
DitchCarbon Score
How does Medacta's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medacta's score of 30 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medacta's reported carbon emissions
In 2024, Medacta reported total carbon emissions of approximately 1,296,000 kg CO2e for Scope 1 and 620,000 kg CO2e for Scope 2, resulting in a combined total of about 1,916,000 kg CO2e. This data reflects their global operations and highlights their commitment to transparency in emissions reporting. For the year 2023, Medacta's emissions in Switzerland (CH) were recorded at approximately 289,000 kg CO2e for Scope 2, while their global emissions for the same year totalled about 949,000 kg CO2e for Scope 1 and 509,000 kg CO2e for Scope 2, culminating in a total of around 1,458,000 kg CO2e. Despite the absence of specific reduction targets or initiatives, Medacta is actively engaged in emissions reporting and has disclosed their emissions data through various sustainability reports. The company does not currently inherit emissions data from a parent organization, ensuring that their reported figures are solely reflective of their own operations. Medacta's commitment to addressing climate change is evident through their detailed emissions disclosures, although they have not yet established specific science-based targets or reduction initiatives. As they continue to monitor and report their emissions, further commitments may be anticipated in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 500,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 0,000,000 |
| Scope 2 | - | - | - | - | - | - | 000,000 | 000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medacta is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
